Why Eric Lefkofsky Is A Medical Technology Warrior

Cancer is a cruel and puzzling foe that has confounded mankind since its beginning. A disease that causes one’s body to become one’s own worst enemy, cancer seems to have any number of causes, but no apparent cures. Unless one is lucky enough to be declared cancer-free in their battle with it, the best that can be hoped for is to arrest and manage the disease with an array of powerful medications. Unfortunately some of these treatments produce serious and sometimes lethal side effects, and it’s not uncommon to hear that these treatments can be worse than the actual cancer.

Fortunately, technological advances correctly administered now mean that health care providers can create individual biological biographies and administer patient cancer care much more effectively. This is made possible in large part through the efforts of Tempus and its co-founder and CEO Eric Lefkofsky.

Tempus is computer software that allows users to map genomes and body functioning on the molecular level in real time, and use this collected data to make decisions about the best course of action involving individual patients. Tempus also delivers a complete report to physicians after patient scanning that includes current information on clinical trials that patients might qualify for, and detailed information on tumors. Tempus also can be used in conjunction with research involving animal trials to develop new types of cancer therapy.

Eric Lefkofsky is no stranger to being involved in shaking up and improving ways of doing things. In addition to his creation and involvement with Tempus, Eric did similar work in setting up Lightbank, a company that funds disruptive technologies. Disruptive technologies are ones that shake up or transform existing technologies. Next-generation genome tracking, self-driving vehicles, natural resource recovery, and cloud platform technologies are all examples of disruptive ones. And not only are these technologies disruptive, they’re transformative, meaning that they’ll impact on how these industries operate far into the future. This means that cancer patients in decades to come will benefit from the efforts of Tempus and Lefkofsky.

In addition to his Tempus and Lightbank work, Lefkofsky has co-founded Uptake, an analytical data company that provides companies with information to help improve company security and safety. In addition to focusing more recently on Tempus, Lefkofsky has become very involved recently in charitable gift giving.

In 2006, he and his wife Elizabeth founded the Lefkofsky Foundation, and since its creation, have given or pledged millions of dollars around the world, including to the Chicago public school system, and a prominent children’s hospital. He is also either a member of or sits on the board of directors of a number of cultural institutions, including the Steppenwolf Theater Company and the Chicago Institute of Art. But Lefkofsky’s touch and instincts aren’t always perfect. He also served on the committee that failed to bring the Summer Olympics to Chicago in 2016.

More information for Lefkofsky: http://www.bizjournals.com/chicago/news/2016/10/20/groupon-founder-eric-lefkofsky-joins-steppenwolf.html

Tech roundup: Lefkofsky’s Tempus comes out of stealth, AddStructure teams up with Target and more